Literature DB >> 28802927

Nonmotor Symptoms in Parkinson's Disease: Gender and Ethnic Differences.

Anna Sauerbier1, Abhishek Lenka2, Azman Aris3, Pramod Kumar Pal4.   

Abstract

Nonmotor symptoms (NMS) are recognized to profoundly affect the quality of life of patients with Parkinson's disease (PD) and of their caregivers. In order to further understand the underlying pathophysiology, clinical presentation, response to medication, and prognosis, it is important to identify and analyze possible factors, which have an impact on PD. Gender and ethnicity have been reported to possibly influence incidence, prevalence, and motor presentation in PD, as well as other neurological conditions. However, the impact of gender and ethnicity on the presentation of NMS in PD is currently unclear. In this chapter, the currently available knowledge about gender and ethnic differences in NMS in PD will be summarized and possible factors that might contribute to those observed differences will be discussed.
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ethnicity; Gender; Nonmotor symptoms; Parkinson's disease

Mesh:

Year:  2017        PMID: 28802927     DOI: 10.1016/bs.irn.2017.05.032

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  7 in total

1.  Frequency of and risk factors for potentially inappropriate medication use in Parkinson's disease.

Authors:  Danielle S Abraham; Thanh Phuong Pham Nguyen; Sean Hennessy; Daniel Weintraub; Shelly L Gray; Dawei Xie; Allison W Willis
Journal:  Age Ageing       Date:  2020-08-24       Impact factor: 10.668

2.  A Cross-Sectional Comprehensive Assessment of the Profile and Burden of Non-motor Symptoms in Relation to Motor Phenotype in the Nigeria Parkinson Disease Registry Cohort.

Authors:  Oluwadamilola O Ojo; Kolawole W Wahab; Abiodun H Bello; Sani A Abubakar; Bertha C Ekeh; Folajimi M Otubogun; Emmanuel U Iwuozo; Temitope H Farombi; Olaleye Adeniji; Francis I Ojini; Frank A Imarhiagbe; Yakub Nyandaiti; Morenikeji A Komolafe; Michael B Fawale; Gerald A Onwuegbuzie; Yusuf Zubair; Uduak E Williams; Funlola T Taiwo; Shyngle I Oyakhire; Olajumoke O Oshinaike; Nosakhare Osemwegie; Godwin O Osaigbovo; Francis E Odiase; Olanike A Odeniyi; Yahaya O Obiabo; Emmanuel E Obehighe; Ernest O Nwazor; Paul O Nwani; Abiodun J Kehinde; Cyril O Erameh; Oluchi S Ekenze; Franklin O Dike; Salisu A Balarabe; Ohwotemu Arigbodi; Babawale Arabambi; Ifeyinwa Ani-Osheku; Mohammed W Ali; John E Akpekpe; Rufus O Akinyemi; Uchechi Agulanna; Christian E Agu; Osigwe P Agabi; Babatunde A Ademiluyi; Akintunde A Adebowale; Charles O Achoru; Oladunni V Abiodun; Mie Rizig; Njideka U Okubadejo
Journal:  Mov Disord Clin Pract       Date:  2021-10-06

3.  Annual Prevalence of Use of Potentially Inappropriate Medications for Treatment of Affective Disorders in Parkinson's Disease.

Authors:  Danielle S Abraham; Thanh Phuong Pham Nguyen; Sean Hennessy; Shelly L Gray; Dawei Xie; Daniel Weintraub; Allison W Willis
Journal:  Am J Geriatr Psychiatry       Date:  2020-05-18       Impact factor: 4.105

4.  The severity progression of non-motor symptoms in Parkinson's disease: a 6-year longitudinal study in Taiwanese patients.

Authors:  Yi-Chieh Chen; Rou-Shayn Chen; Yi-Hsin Weng; Ying-Zu Huang; Chiung Chu Chen; June Hung; Yi-Ying Lin
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

5.  Abnormalities in the white matter tracts in patients with Parkinson disease and psychosis.

Authors:  Abhishek Lenka; Madhura Ingalhalikar; Apurva Shah; Jitender Saini; Shyam Sundar Arumugham; Shantala Hegde; Lija George; Ravi Yadav; Pramod Kumar Pal
Journal:  Neurology       Date:  2020-04-21       Impact factor: 11.800

Review 6.  Apathy in Parkinson's Disease: Defining the Park Apathy Subtype.

Authors:  Ségolène De Waele; Patrick Cras; David Crosiers
Journal:  Brain Sci       Date:  2022-07-14

7.  A Pitx3-deficient developmental mouse model for fine motor, olfactory, and gastrointestinal symptoms of Parkinson's disease.

Authors:  Bin Song; Jacob W Feldmann; Shibo Cao; Melissa Feitosa; Youngbin Kong; Woori Kim; Altana Schweitzer; Pierre Leblanc; Jeffrey S Schweitzer; Kwang-Soo Kim
Journal:  Neurobiol Dis       Date:  2022-05-27       Impact factor: 7.046

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.